Chronic obstructive pulmonary disorder (COPD) is the 4th leading cause of death in the United States, killing more than 3 million people every year. Additionally, the rates of COPD are rapidly growing creating a $3 billion US market opportunity. At SaiOx, our patented breathing device utilizes the proven benefits of heliox technology in a novel system to provide relief to the 24 million Americans suffering with COPD. We believe that this technology will disrupt the current medical device market and provide a more efficient solution to the ongoing problem.